false
Q2
2026
--12-31
0001883835
0001883835
2026-01-01
2026-06-30
0001883835
2026-08-14
0001883835
2026-06-30
0001883835
2025-12-31
0001883835
2026-04-01
2026-06-30
0001883835
2025-04-01
2025-06-30
0001883835
2025-01-01
2025-06-30
0001883835
us-gaap:CommonStockMember
2025-12-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001883835
esgh:APICIssuableMember
2025-12-31
0001883835
us-gaap:RetainedEarningsMember
2025-12-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001883835
esgh:ESGIncEquityMember
2025-12-31
0001883835
us-gaap:NoncontrollingInterestMember
2025-12-31
0001883835
us-gaap:CommonStockMember
2026-03-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2026-03-31
0001883835
esgh:APICIssuableMember
2026-03-31
0001883835
us-gaap:RetainedEarningsMember
2026-03-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-03-31
0001883835
esgh:ESGIncEquityMember
2026-03-31
0001883835
us-gaap:NoncontrollingInterestMember
2026-03-31
0001883835
2026-03-31
0001883835
us-gaap:CommonStockMember
2024-12-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001883835
esgh:APICIssuableMember
2024-12-31
0001883835
us-gaap:RetainedEarningsMember
2024-12-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001883835
esgh:ESGIncEquityMember
2024-12-31
0001883835
us-gaap:NoncontrollingInterestMember
2024-12-31
0001883835
2024-12-31
0001883835
us-gaap:CommonStockMember
2025-03-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0001883835
esgh:APICIssuableMember
2025-03-31
0001883835
us-gaap:RetainedEarningsMember
2025-03-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0001883835
esgh:ESGIncEquityMember
2025-03-31
0001883835
us-gaap:NoncontrollingInterestMember
2025-03-31
0001883835
2025-03-31
0001883835
us-gaap:CommonStockMember
2026-01-01
2026-03-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-03-31
0001883835
esgh:APICIssuableMember
2026-01-01
2026-03-31
0001883835
us-gaap:RetainedEarningsMember
2026-01-01
2026-03-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-03-31
0001883835
esgh:ESGIncEquityMember
2026-01-01
2026-03-31
0001883835
us-gaap:NoncontrollingInterestMember
2026-01-01
2026-03-31
0001883835
2026-01-01
2026-03-31
0001883835
us-gaap:CommonStockMember
2026-04-01
2026-06-30
0001883835
us-gaap:AdditionalPaidInCapitalMember
2026-04-01
2026-06-30
0001883835
esgh:APICIssuableMember
2026-04-01
2026-06-30
0001883835
us-gaap:RetainedEarningsMember
2026-04-01
2026-06-30
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-04-01
2026-06-30
0001883835
esgh:ESGIncEquityMember
2026-04-01
2026-06-30
0001883835
us-gaap:NoncontrollingInterestMember
2026-04-01
2026-06-30
0001883835
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0001883835
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-03-31
0001883835
esgh:APICIssuableMember
2025-01-01
2025-03-31
0001883835
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-03-31
0001883835
esgh:ESGIncEquityMember
2025-01-01
2025-03-31
0001883835
us-gaap:NoncontrollingInterestMember
2025-01-01
2025-03-31
0001883835
2025-01-01
2025-03-31
0001883835
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0001883835
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-06-30
0001883835
esgh:APICIssuableMember
2025-04-01
2025-06-30
0001883835
us-gaap:RetainedEarningsMember
2025-04-01
2025-06-30
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-04-01
2025-06-30
0001883835
esgh:ESGIncEquityMember
2025-04-01
2025-06-30
0001883835
us-gaap:NoncontrollingInterestMember
2025-04-01
2025-06-30
0001883835
us-gaap:CommonStockMember
2026-06-30
0001883835
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001883835
esgh:APICIssuableMember
2026-06-30
0001883835
us-gaap:RetainedEarningsMember
2026-06-30
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001883835
esgh:ESGIncEquityMember
2026-06-30
0001883835
us-gaap:NoncontrollingInterestMember
2026-06-30
0001883835
us-gaap:CommonStockMember
2025-06-30
0001883835
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001883835
esgh:APICIssuableMember
2025-06-30
0001883835
us-gaap:RetainedEarningsMember
2025-06-30
0001883835
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001883835
esgh:ESGIncEquityMember
2025-06-30
0001883835
us-gaap:NoncontrollingInterestMember
2025-06-30
0001883835
2025-06-30
0001883835
esgh:ESGChinaLimitedMember
2026-04-01
2026-05-26
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2026-04-01
2026-05-26
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2026-04-01
2026-06-30
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2026-05-26
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2025-12-31
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2025-04-01
2025-06-30
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2026-01-01
2026-05-26
0001883835
us-gaap:SegmentDiscontinuedOperationsMember
2026-01-01
2026-06-30
0001883835
esgh:LabrysFundIILPMember
2025-08-05
0001883835
esgh:LabrysFundIILPMember
2025-08-01
2025-08-05
0001883835
esgh:LabrysNoteMember
2026-02-01
2026-02-06
0001883835
esgh:LabrysNoteMember
2026-02-06
0001883835
esgh:LabrysNoteMember
2026-04-01
2026-04-13
0001883835
esgh:LabrysNoteMember
2026-04-13
0001883835
esgh:LabrysNoteMember
2026-04-01
2026-06-30
0001883835
esgh:LabrysNoteMember
2026-06-30
0001883835
esgh:MonroeStreetCapitalPartnersLPMember
2026-03-06
0001883835
esgh:CromStructuredOpportunitiesFundILPMember
2026-03-09
0001883835
2026-03-01
2026-03-06
0001883835
esgh:MonroeStreetCapitalPartnersLPMember
2026-03-01
2026-03-06
0001883835
esgh:CromStructuredOpportunitiesFundILPMember
2026-03-01
2026-03-09
0001883835
2024-10-17
2024-12-31
0001883835
2025-01-01
2025-12-31
0001883835
esgh:SevenCurrentAndFormerDirectorsMember
2026-05-29
2026-06-01
0001883835
srt:ScenarioPreviouslyReportedMember
2025-12-31
0001883835
srt:RestatementAdjustmentMember
2025-12-31
0001883835
srt:ScenarioPreviouslyReportedMember
2025-04-01
2025-06-30
0001883835
srt:RestatementAdjustmentMember
2025-04-01
2025-06-30
0001883835
srt:ScenarioPreviouslyReportedMember
2025-01-01
2025-06-30
0001883835
srt:RestatementAdjustmentMember
2025-01-01
2025-06-30
0001883835
srt:ScenarioPreviouslyReportedMember
2026-01-01
2026-03-31
0001883835
srt:RestatementAdjustmentMember
2026-01-01
2026-03-31
0001883835
us-gaap:SubsequentEventMember
esgh:LabrysNoteMember
2026-08-01
2026-08-07
0001883835
us-gaap:SubsequentEventMember
esgh:LabrysNoteMember
2026-08-02
2026-08-13
0001883835
us-gaap:SubsequentEventMember
esgh:ForbearanceArrangementMember
2026-08-01
2026-08-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☒ | Quarterly Report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 |
For the quarterly period ended June 30, 2026
| ☐ | Transition Report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 |
For the transition period from __________ to __________
Commission File Number: 000-56532
ESG INC.
(Exact name of registrant as specified in its charter)
| Nevada |
87-1918342 |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
433 East Hillendale Road, Chadds Ford, PA 19317
(Address of Principal Executive Offices) (Zip Code)
267-467-5871
(Registrant’s telephone number, including
area code)
N/A
(Former Name, former address and former fiscal
year, if changed since last report)
Securities registered under Section 12(b) of the Exchange Act: None
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit such files). Yes ☒
No ☐
Large accelerated filer ☐
Accelerated filer ☐ Non-accelerated filer ☒
Smaller reporting company ☒ Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
15,591,376 shares of common stock issued and outstanding as of August
14, 2026.
ESG INC.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
| PART I |
FINANCIAL INFORMATION |
|
| Item 1. |
Financial Statements (Unaudited) |
F-1 |
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
1 |
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
4 |
| Item 4. |
Controls and Procedures |
4 |
| PART II |
OTHER INFORMATION |
|
| Item 1. |
Legal Proceedings |
5 |
| Item 1A. |
Risk Factors |
5 |
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
5 |
| Item 3. |
Defaults Upon Senior Securities |
5 |
| Item 4. |
Mine Safety Disclosures |
6 |
| Item 5. |
Other Information |
6 |
| Item 6. |
Exhibits |
7 |
| |
Signatures |
8 |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
ESG INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
| | |
| | | |
| | |
| | |
June 30, 2026 | | |
December 31, 2025,
As Revised | |
| Assets | |
| | | |
| | |
| Current assets | |
| | | |
| | |
| Cash | |
$ | 161,100 | | |
$ | 42,505 | |
| Inventories | |
| 29,645 | | |
| — | |
| Current assets of discontinued operations | |
| — | | |
| 6,746,812 | |
| Total current assets | |
| 190,745 | | |
| 6,789,317 | |
| | |
| | | |
| | |
| Property, plant and equipment, net | |
| 32 | | |
| 162 | |
| Noncurrent assets of discontinued operations | |
| — | | |
| 20,143,680 | |
| Total noncurrent assets | |
| 32 | | |
| 20,143,842 | |
| | |
| | | |
| | |
| Total assets | |
$ | 190,777 | | |
$ | 26,933,159 | |
| | |
| | | |
| | |
| Liabilities and stockholders’ equity | |
| | | |
| | |
| Current liabilities | |
| | | |
| | |
| Accounts payable | |
$ | 64,324 | | |
$ | 84,409 | |
| Accrued interest payable | |
| 19,522 | | |
| — | |
| Convertible notes payable, net | |
| 481,070 | | |
| 275,000 | |
| Current liabilities of discontinued operations | |
| — | | |
| 12,738,332 | |
| Total current liabilities | |
| 564,916 | | |
| 13,097,741 | |
| Noncurrent liabilities of discontinued operations | |
| — | | |
| 1,983,300 | |
| | |
| | | |
| | |
| Total liabilities | |
| 564,916 | | |
| 15,081,041 | |
| | |
| | | |
| | |
| Commitments and contingencies | |
| | | |
| | |
| | |
| | | |
| | |
| Stockholders’ equity | |
| | | |
| | |
| Common stock, $0.001 par value; 65,000,000 shares authorized; 15,591,376 and 25,899,468 shares issued and outstanding, respectively | |
| 15,592 | | |
| 25,900 | |
| Additional paid-in capital | |
| 686,412 | | |
| 11,152,388 | |
| Additional paid-in capital issuable | |
| — | | |
| 444,096 | |
| Accumulated other comprehensive loss | |
| — | | |
| (310,877 | ) |
| Accumulated deficit | |
| (1,076,143 | ) | |
| (2,560,014 | ) |
| Total ESG Inc. stockholders’ equity (deficit) | |
| (374,139 | ) | |
| 8,751,493 | |
| Noncontrolling interest | |
| — | | |
| 3,100,625 | |
| Total equity (deficit) | |
| (374,139 | ) | |
| 11,852,118 | |
| | |
| | | |
| | |
| Total liabilities and equity | |
$ | 190,777 | | |
$ | 26,933,159 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
ESG INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
| | |
| | | |
| | | |
| | | |
| | |
| | |
Three
Months Ended June 30, 2026 | | |
Three Months Ended June 30, 2025, As Revised | | |
Six
Months Ended June 30, 2026 | | |
Six Months Ended June 30, 2025, As Revised | |
| Continuing operations | |
| | | |
| | | |
| | | |
| | |
| Revenue | |
$ | 918 | | |
$ | — | | |
$ | 918 | | |
$ | — | |
| Cost of goods sold | |
| 555 | | |
| — | | |
| 555 | | |
| — | |
| | |
| | | |
| | | |
| | | |
| | |
| Gross profit | |
| 363 | | |
| — | | |
| 363 | | |
| — | |
| | |
| | | |
| | | |
| | | |
| | |
| Selling, general and administrative expense | |
| 1,610 | | |
| 96,074 | | |
| 126,863 | | |
| 193,115 | |
| Professional fees | |
| — | | |
| — | | |
| 15,820 | | |
| 20,500 | |
| Total operating expenses | |
| 1,610 | | |
| 96,074 | | |
| 142,683 | | |
| 213,615 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss from operations | |
| (1,247 | ) | |
| (96,074 | ) | |
| (142,320 | ) | |
| (213,615 | ) |
| Interest expense | |
| 26,036 | | |
| — | | |
| 32,817 | | |
| — | |
| | |
| | | |
| | | |
| | | |
| | |
| Income-tax expense | |
| — | | |
| — | | |
| — | | |
| — | |
| Net loss from continuing operations | |
| (27,283 | ) | |
| (96,074 | ) | |
| (175,137 | ) | |
| (213,615 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Discontinued operations | |
| | | |
| | | |
| | | |
| | |
| Income (loss) from discontinued China operations, net of tax | |
| (46,206 | ) | |
| 701,917 | | |
| (878,342 | ) | |
| 452,745 | |
| Net income (loss) | |
| (73,489 | ) | |
| 605,843 | | |
| (1,053,479 | ) | |
| 239,130 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) attributable to ESG Inc. | |
| (63,297 | ) | |
| 426,995 | | |
| (841,451 | ) | |
| 123,771 | |
| Net income (loss) attributable to noncontrolling interest | |
| (10,192 | ) | |
| 178,848 | | |
| (212,028 | ) | |
| 115,359 | |
| Foreign-currency translation adjustment attributable to ESG Inc. before reclassification | |
| 134,585 | | |
| 129,638 | | |
| 264,671 | | |
| 421,524 | |
| Reclassification adjustment for cumulative foreign-currency translation loss included in discontinued operations | |
| 46,206 | | |
| — | | |
| 46,206 | | |
| — | |
| Other comprehensive income attributable to noncontrolling interest | |
| 52,454 | | |
| 44,326 | | |
| 96,933 | | |
| 144,128 | |
| Comprehensive income (loss) | |
| 159,756 | | |
| 779,807 | | |
| (645,669 | ) | |
| 804,782 | |
| | |
| | | |
| | | |
| | | |
| | |
| Less: comprehensive income (loss) attributable to noncontrolling interest | |
| 42,262 | | |
| 223,174 | | |
| (115,095 | ) | |
| 259,487 | |
| | |
| | | |
| | | |
| | | |
| | |
| Comprehensive income (loss) attributable to ESG Inc. | |
$ | 117,494 | | |
$ | 556,633 | | |
$ | (530,574 | ) | |
$ | 545,295 | |
| Continuing operations—basic and diluted | |
$ | (0.00 | ) | |
$ | (0.00 | ) | |
$ | (0.01 | ) | |
$ | (0.01 | ) |
| Discontinued operations—basic and diluted | |
$ | (0.00 | ) | |
$ | 0.02 | | |
$ | (0.03 | ) | |
$ | 0.01 | |
| Net income (loss)—basic and diluted | |
$ | (0.00 | ) | |
$ | 0.02 | | |
$ | (0.04 | ) | |
$ | 0.00 | |
| Weighted-average shares outstanding - basic and diluted | |
| 21,818,427 | | |
| 25,899,468 | | |
| 23,848,509 | | |
| 25,899,468 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
ESG INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CHANGES IN STOCKHOLDERS’ EQUITY
For the Six Months Ended June 30, 2026 and 2025
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| 2026 | |
Common Stock Shares | | |
Common Stock Amount | | |
Additional Paid-in Capital | | |
APIC Issuable | | |
Accumulated Deficit | | |
AOCI | | |
ESG Inc. Equity | | |
NCI | | |
Total Equity | |
| Balance at December 31, 2025, as revised | |
| 25,899,468 | | |
$ | 25,900 | | |
$ | 11,152,388 | | |
$ | 444,096 | | |
$ | (2,560,014 | ) | |
$ | (310,877 | ) | |
$ | 8,751,493 | | |
$ | 3,100,625 | | |
$ | 11,852,118 | |
| Labrys note conversion - February 6, 2026 | |
| 2,800 | | |
| 3 | | |
| 11,718 | | |
| - | | |
| - | | |
| - | | |
| 11,721 | | |
| - | | |
| 11,721 | |
| Share-based compensation recognized for Q1 2026 | |
| - | | |
| - | | |
| - | | |
| 95,939 | | |
| - | | |
| - | | |
| 95,939 | | |
| - | | |
| 95,939 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (778,154 | ) | |
| - | | |
| (778,154 | ) | |
| (201,836 | ) | |
| (979,990 | ) |
| Foreign-currency translation adjustment | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 130,086 | | |
| 130,086 | | |
| 44,479 | | |
| 174,565 | |
| Balance at March 31, 2026 | |
| 25,902,268 | | |
| 25,903 | | |
| 11,164,106 | | |
| 540,035 | | |
| (3,338,168 | ) | |
| (180,791 | ) | |
| 8,211,085 | | |
| 2,943,268 | | |
| 11,154,353 | |
| Labrys note conversion - April 13, 2026 | |
| 6,000 | | |
| 6 | | |
| 10,074 | | |
| - | | |
| - | | |
| - | | |
| 10,080 | | |
| - | | |
| 10,080 | |
| Issuance of compensation shares and settlement of APIC issuable - June 1, 2026 | |
| 115,908 | | |
| 116 | | |
| 539,919 | | |
| (540,035 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Current-period foreign-currency translation adjustment through May 26, 2026 | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 134,585 | | |
| 134,585 | | |
| 52,454 | | |
| 187,039 | |
| Reclassification of cumulative translation loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 46,206 | | |
| 46,206 | | |
| - | | |
| 46,206 | |
| Cancellation of shares in China split-off - May 26, 2026 | |
| (10,432,800 | ) | |
| (10,433 | ) | |
| (11,027,687 | ) | |
| - | | |
| 2,325,322 | | |
| - | | |
| (8,712,798 | ) | |
| - | | |
| (8,712,798 | ) |
| Derecognition of ESG China noncontrolling interest | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (2,985,530 | ) | |
| (2,985,530 | ) |
| Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (63,297 | ) | |
| - | | |
| (63,297 | ) | |
| (10,192 | ) | |
| (73,489 | ) |
| Balance at June 30, 2026 | |
| 15,591,376 | | |
$ | 15,592 | | |
$ | 686,412 | | |
$ | - | | |
$ | (1,076,143 | ) | |
$ | - | | |
$ | (374,139 | ) | |
$ | - | | |
$ | (374,139 | ) |
2025 Comparative Period - As Revised
| 2025 | |
Common Stock Shares | | |
Common Stock Amount | | |
Additional Paid-in Capital | | |
APIC Issuable | | |
Accumulated Deficit | | |
AOCI | | |
ESG Inc. Equity | | |
NCI | | |
Total Equity | |
| Balance at December 31, 2024, as revised | |
| 25,899,468 | | |
$ | 25,900 | | |
$ | 11,152,388 | | |
$ | 74,432 | | |
$ | (243,032 | ) | |
$ | (711,270 | ) | |
$ | 10,298,418 | | |
$ | 3,519,577 | | |
$ | 13,817,995 | |
| Share-based compensation recognized for Q1 2025 | |
| - | | |
| - | | |
| - | | |
| 90,559 | | |
| - | | |
| - | | |
| 90,559 | | |
| - | | |
| 90,559 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (303,223 | ) | |
| - | | |
| (303,223 | ) | |
| (63,489 | ) | |
| (366,712 | ) |
| Foreign-currency translation adjustment | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 291,886 | | |
| 291,886 | | |
| 99,802 | | |
| 391,688 | |
| Balance at March 31, 2025 | |
| 25,899,468 | | |
| 25,900 | | |
| 11,152,388 | | |
| 164,991 | | |
| (546,255 | ) | |
| (419,384 | ) | |
| 10,377,640 | | |
| 3,555,890 | | |
| 13,933,530 | |
| Share-based compensation recognized for Q2 2025 | |
| - | | |
| - | | |
| - | | |
| 90,559 | | |
| - | | |
| - | | |
| 90,559 | | |
| - | | |
| 90,559 | |
| Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| 426,995 | | |
| - | | |
| 426,995 | | |
| 178,848 | | |
| 605,843 | |
| Foreign-currency translation adjustment | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 129,638 | | |
| 129,638 | | |
| 44,326 | | |
| 173,964 | |
| Balance at June 30, 2025 | |
| 25,899,468 | | |
$ | 25,900 | | |
$ | 11,152,388 | | |
$ | 255,550 | | |
$ | (119,260 | ) | |
$ | (289,746 | ) | |
$ | 11,024,832 | | |
$ | 3,779,064 | | |
$ | 14,803,896 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
ESG INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS
| | |
| | | |
| | |
| | |
Six Months Ended
June 30, 2026 | | |
Six Months Ended
June 30, 2025,
As Revised | |
| Cash flows from operating activities | |
| | | |
| | |
| Net loss from continuing operations | |
$ | (175,137 | ) | |
$ | (213,615 | ) |
| Adjustments to reconcile net loss to net cash used in continuing operating activities: | |
| | | |
| | |
| Share-based compensation expense | |
| 95,939 | | |
| 181,119 | |
| Amortization of debt discount | |
| 6,070 | | |
| - | |
| Depreciation and amortization | |
| 130 | | |
| 130 | |
| Stock issuance for interest expense | |
| 18,301 | | |
| - | |
| Changes in operating assets and liabilities: | |
| | | |
| | |
| Inventories | |
| (29,645 | ) | |
| - | |
| Accounts payable | |
| (20,085 | ) | |
| (8,626 | ) |
| Accrued interest payable | |
| 19,522 | | |
| - | |
| Net cash used in operating activities - continuing operations | |
| (84,905 | ) | |
| (40,992 | ) |
| | |
| | | |
| | |
| Net cash provided by (used in) operating activities - discontinued operations | |
| 27,058 | | |
| (1,490,285 | ) |
| Net cash used in operating activities | |
| (57,847 | ) | |
| (1,531,277 | ) |
| | |
| | | |
| | |
| Cash flows from investing activities | |
| | | |
| | |
| Net cash used in investing activities - continuing operations | |
| - | | |
| - | |
| Net cash used in investing activities - discontinued operations | |
| - | | |
| (208,253 | ) |
| Net cash used in investing activities | |
| - | | |
| (208,253 | ) |
| | |
| | | |
| | |
| Cash flows from financing activities | |
| | | |
| | |
| Proceeds from convertible notes | |
| 200,000 | | |
| - | |
| Net cash provided by financing activities - continuing operations | |
| 200,000 | | |
| - | |
| Net cash provided by financing activities - discontinued operations | |
| - | | |
| 1,341,253 | |
| Net cash provided by financing activities | |
| 200,000 | | |
| 1,341,253 | |
| | |
| | | |
| | |
| Cash and restricted cash transferred with the China split-off | |
| (38,493 | ) | |
| - | |
| Effect of exchange-rate changes on cash and restricted cash | |
| (22,431 | ) | |
| 360,909 | |
| Net increase (decrease) in cash and restricted cash | |
| 81,229 | | |
| (37,369 | ) |
| | |
| | | |
| | |
| Cash and restricted cash, beginning of period | |
| 79,871 | | |
| 166,741 | |
| Cash, end of period | |
$ | 161,100 | | |
$ | 129,372 | |
Supplemental disclosures of non-cash investing and financing activities:
On June 1, 2026, the Company issued 115,908 restricted shares of common
stock in settlement of $540,035.48 previously recorded within additional paid-in capital issuable. The issuance had no effect on total
stockholders’ equity or cash flows.
On May 26, 2026, the Company distributed the net assets of ESG China
Limited in connection with the split-off and canceled 10,432,800 shares of its common stock. The transaction was principally noncash.
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
Note 1 - Basis of Presentation
The accompanying unaudited condensed consolidated financial statements
include the accounts of ESG Inc. and its subsidiaries (collectively, the “Company,” “ESG,” “we,” “us”
or “our”). All material intercompany accounts and transactions have been eliminated.
In the opinion of management, the unaudited condensed consolidated
financial statements include all adjustments necessary for a fair presentation of the Company’s financial position, results of operations
and cash flows for the periods presented. Except for the revisions described in Note 7, such adjustments are of a normal recurring nature.
These unaudited condensed consolidated financial statements should
be read together with the audited consolidated financial statements and related notes included in the Company’s Annual Report on
Form 10-K for the year ended December 31, 2025. The results for interim periods are not necessarily indicative of results expected for
the full fiscal year or any future period.
Note 2 - Going Concern
The accompanying unaudited condensed consolidated financial statements
have been prepared on a going-concern basis, which assumes that the Company will continue in operation and realize its assets and discharge
its liabilities in the ordinary course of business.
Following completion of the split-off of the Company’s China
operations on May 26, 2026, the Company’s continuing operations are in an early stage and have generated limited revenue. For the
six months ended June 30, 2026, the Company incurred a loss from continuing operations of $175,137 and used $84,905 of cash in continuing
operating activities.
As of June 30, 2026, the Company had cash of $161,100, current assets
of $190,745, current liabilities of $564,916 and a working-capital deficit of $374,171. The Company also remained in default under the
Labrys Fund II, L.P. convertible promissory note described in Note 6.
The Company’s existing cash resources and anticipated operating
cash flows are not expected to be sufficient to satisfy its operating and financing obligations for the twelve months following issuance
of these financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
Management’s plans include seeking additional debt or equity
financing, negotiating extensions, conversions or modifications of outstanding indebtedness, controlling operating expenses, commercializing
the Company’s North American food and snack products and evaluating strategic transactions. There can be no assurance that financing
will be available when required or on acceptable terms or that management’s plans will be successfully implemented. Management’s
plans have not alleviated the substantial doubt, and the financial statements do not include adjustments that might result from the outcome
of this uncertainty.
Note 3 – Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards
Codification Topic 606, Revenue from Contracts with Customers. Revenue is recognized when control of promised goods is transferred
to a customer in an amount that reflects the consideration the Company expects to receive.
Following classification of the former PRC operations as discontinued
operations, the Company recognized $918 of revenue from continuing operations for both the three and six months ended June 30, 2026 and
no revenue for the corresponding 2025 periods.
Revenue generated by the former PRC operations has been retrospectively
classified within discontinued operations for all periods presented. See Note 4.
As of June 30, 2026, the Company had no material contract assets, contract
liabilities or remaining performance obligations related to continuing operations.
Note 4 - Split-Off and Discontinued Operations
On May 26, 2026, the Company completed the split-off of ESG China Limited
and its subsidiaries pursuant to the Split-Off and Share Exchange Agreement dated April 10, 2026. In connection with the transaction,
the Company transferred all of the outstanding equity interests of ESG China Limited in exchange for the surrender, redemption, retirement
and cancellation of 10,432,800 shares of the Company’s common stock.
The transaction was a related-party transaction because the Company’s
Chief Executive Officer and a director controlled DCG China Limited, one of the counterparties. Upon completion of the transaction, the
Company ceased to own or control ESG China Limited and its subsidiaries.
The split-off represented a strategic shift that had a major effect
on the Company’s operations and financial results. Accordingly, the results of the former China operations through May 26, 2026
are presented as discontinued operations for all periods presented. Comparative prior-period results have been reclassified to conform
to the current presentation.
Upon deconsolidation, the Company derecognized the assets, liabilities
and noncontrolling interests associated with the China operations. The Company also reclassified the remaining cumulative foreign-currency
translation loss attributable to ESG Inc. of $46,206 from accumulated other comprehensive loss into discontinued operations. A corresponding
reclassification adjustment was included in other comprehensive income, and the reclassification had no effect on total comprehensive
income or cash flows.
For the three months ended June 30, 2026, loss from discontinued operations for that period was therefore
$46,206. For the six months ended June 30, 2026, operating loss from discontinued operations was $832,136 and total loss from discontinued
operations, including the CTA reclassification, was $878,342.
The Company recognized no additional gain or loss from the difference
between the carrying amount of the net assets distributed and the related consideration. As of June 30, 2026, no assets or liabilities
attributable to the former China operations remained on the Company’s consolidated balance sheet, and the Company had no significant
continuing involvement with those operations. Separately, during the second quarter of 2026, the Company recorded a $10,192 attribution
adjustment between ESG Inc. and the noncontrolling interest. The adjustment affected only the attribution of consolidated net loss
between ESG Inc. and the noncontrolling interest and had no effect on consolidated net loss, loss from discontinued operations, total
comprehensive income (loss), or total stockholders’ equity.
Major classes of assets and liabilities of discontinued operations:
Schedule of assets and liabilities of
discontinued operations
| |
| | |
| |
| | |
May 26, 2026 | | |
December 31, 2025 | |
| Assets | |
| | |
| |
| Cash | |
$ | - | | |
$ | 474 | |
| Restricted cash | |
| 38,493 | | |
| 36,892 | |
| Accounts receivable | |
| 3,136,960 | | |
| 3,223,334 | |
| Inventories | |
| 115,639 | | |
| 112,250 | |
| Other receivables | |
| 445,514 | | |
| 432,458 | |
| Advances to suppliers | |
| 862,425 | | |
| 837,152 | |
| Value-added tax receivable, current | |
| 2,104,253 | | |
| 2,104,252 | |
| Total current assets | |
| 6,703,284 | | |
| 6,746,812 | |
| Property, plant and equipment, net | |
| 16,318,564 | | |
| 16,313,249 | |
| Intangible assets, net | |
| 3,064,945 | | |
| 2,992,157 | |
| Value-added tax receivable, noncurrent | |
| 926,708 | | |
| 838,274 | |
| Total noncurrent assets | |
| 20,310,217 | | |
| 20,143,680 | |
| Total assets | |
$ | 27,013,501 | | |
$ | 26,890,492 | |
| Liabilities | |
| | | |
| | |
| Short-term bank loans | |
$ | 6,332,376 | | |
$ | 6,146,809 | |
| Accounts payable | |
| 1,493,786 | | |
| 1,450,012 | |
| Accrued expenses and other current liabilities | |
| 5,402,497 | | |
| 5,030,921 | |
| Deferred income, current | |
| 110,590 | | |
| 110,590 | |
| Total current liabilities | |
| 13,339,249 | | |
| 12,738,332 | |
| Deferred income, noncurrent | |
| 1,030,117 | | |
| 1,022,465 | |
| Long-term payable | |
| 945,807 | | |
| 960,835 | |
| Total noncurrent liabilities | |
| 1,975,924 | | |
| 1,983,300 | |
| Total liabilities | |
$ | 15,315,173 | | |
$ | 14,721,632 | |
Major classes of income and expense of discontinued operations:
| Schedule of income and expense of discontinued operations | |
| | | |
| | |
| | |
Three Months Ended
June 30, 2026 | | |
Three Months Ended
June 30, 2025 | |
| Revenue | |
$ | - | | |
$ | 2,490,036 | |
| Cost of revenue | |
| - | | |
| 1,407,670 | |
| Selling, general and administrative expenses | |
| - | | |
| 115,419 | |
| Research and development expense | |
| - | | |
| 155,053 | |
| Interest income (expense), net | |
| - | | |
| (133,921 | ) |
| Other income | |
| - | | |
| 23,944 | |
| Operating income (loss) before CTA reclassification | |
| - | | |
| 701,917 | |
| CTA reclassification loss | |
| (46,206 | ) | |
| - | |
| Income (loss) from discontinued operations | |
$ | (46,206 | ) | |
$ | 701,917 | |
| | |
| | | |
| | |
| | |
Period Ended
May 26, 2026 | | |
Six Months Ended
June 30, 2025 | |
| Revenue | |
$ | - | | |
$ | 4,077,180 | |
| Cost of revenue | |
| - | | |
| 2,913,882 | |
| Selling, general and administrative expenses | |
| 734,324 | | |
| 377,768 | |
| Research and development expense | |
| - | | |
| 221,376 | |
| Interest expense | |
| 124,081 | | |
| 264,323 | |
| Other income, net | |
| 26,269 | | |
| 152,914 | |
| Operating income (loss) | |
| (832,136 | ) | |
| 452,745 | |
| CTA reclassification loss | |
| (46,206 | ) | |
| - | |
| Income (loss) from discontinued operations | |
$ | (878,342 | ) | |
$ | 452,745 | |
Note 5 - Segment Reporting
Following completion of the split-off on May 26, 2026, the Company
operates as one operating and reportable segment consisting of its continuing North American food and snack operations. The Company’s
Chief Executive Officer is the chief operating decision maker (the “CODM”).
The CODM evaluates the segment principally based on revenue and loss
from continuing operations and reviews significant expense categories including cost of goods sold, selling, general and administrative
expenses, professional fees and interest expense. The CODM uses this information to assess performance and allocate resources.
The former PRC operations have been classified as discontinued operations
and are excluded from the continuing segment information.
| Schedule of operating segment | |
| | | |
| | | |
| | | |
| | |
| | |
Q2 2026 | | |
Q2 2025, As Revised | | |
Six Months 2026 | | |
Six Months 2025,
As Revised | |
| Revenue | |
$ | 918 | | |
$ | - | | |
$ | 918 | | |
$ | - | |
| Cost of goods sold | |
| 555 | | |
| - | | |
| 555 | | |
| - | |
| Selling, general and administrative expenses | |
| 1,610 | | |
| 96,074 | | |
| 126,863 | | |
| 193,115 | |
| Professional fees | |
| - | | |
| - | | |
| 15,820 | | |
| 20,500 | |
| Interest expense | |
| 26,036 | | |
| - | | |
| 32,817 | | |
| - | |
| Segment loss | |
$ | (27,283 | ) | |
$ | (96,074 | ) | |
$ | (175,137 | ) | |
$ | (213,615 | ) |
Total segment assets, which equal consolidated assets, were $190,777
as of June 30, 2026.
Note 6 - Convertible Notes and Warrants
Convertible notes payable consisted of the following as of June 30,
2026:
| Schedule of Convertible notes payable | |
| | |
| | |
Amount | |
| Aggregate principal | |
$ | 495,000 | |
| Less: unamortized debt discount | |
| (13,930 | ) |
| Convertible notes payable, net | |
$ | 481,070 | |
Labrys Fund II, L.P.
On August 5, 2025, the Company issued an unsecured convertible
promissory note to Labrys Fund II, L.P. in the principal amount of $275,000
for cash proceeds of $250,000,
reflecting an original issue discount of $25,000.
The note bears interest at 10% per annum and had a stated maturity date of August 5, 2026. In connection with the financing, the Company also issued Labrys a
warrant to purchase 45,833 shares of common stock at an initial exercise price of $6.00 per share.
The Company did not make the $151,250 amortization payment due on February
5, 2026. The failure constituted an Event of Default and triggered the holder’s acceleration and default-conversion rights. The
Company made no scheduled cash amortization payments through June 30, 2026. Scheduled payments in arrears as of June 30, 2026 aggregated
$252,083.32, and the outstanding principal remained $275,000.
On February 6, 2026, the holder converted $9,970.52 of accrued interest
and a $1,750 conversion fee, totaling $11,720.52, into 2,800 shares at $4.1859 per share. On April 13, 2026, the holder converted $8,330
of accrued interest and a $1,750 conversion fee, totaling $10,080, into 6,000 shares at $1.68 per share. Neither conversion reduced principal.
Under the terms of the note, principal or interest not paid when due
bears default interest at the lesser of 22% per annum or the maximum rate permitted by law, calculated on the basis of a 365-day year
and the actual number of days elapsed.
During preparation of the financial statements
for the quarter ended June 30, 2026, the Company recognized approximately $13,110 of additional default interest under the Labrys
note. The adjustment was recognized in interest expense during the second quarter of 2026. Total accrued interest payable was $19,522
as of June 30, 2026. The adjustment did not reduce the outstanding principal balance of the Labrys note.
The note permits the holder, following an Event of Default, to claim
a contractual default amount equal to 150% of outstanding principal and accrued interest, including applicable default interest, together
with collection costs. No written waiver, amendment, extension or forbearance agreement had been entered into as of June 30, 2026. See
Note 9 for subsequent developments concerning a temporary forbearance arrangement reached with the holder after June 30, 2026.
Monroe Street Capital Partners, LP and Crom Structured Opportunities
Fund I, LP
On March 6 and March 9, 2026, the Company issued unsecured convertible
promissory notes in the principal amount of $110,000 each to Monroe Street Capital Partners, LP and Crom Structured Opportunities Fund
I, LP, respectively, for aggregate cash proceeds of $200,000. Each note reflects a $10,000 original issue discount and includes a one-time
$11,000 interest charge.
The Monroe note matures on March 6, 2027, and the Crom note matures
on March 9, 2027. No scheduled principal or interest payment was due under either note as of June 30, 2026, and no amount under either
note had been converted.
In connection with the notes, the Company issued each investor a warrant
to purchase 18,333 shares of common stock at an exercise price of $6.00 per share.
The potential common shares issuable under the notes and warrants were
excluded from diluted loss-per-share calculations because their effect would have been antidilutive.
Note 7 - Share-Based Compensation and Revision of Prior-Period Financial
Statements
On October 17, 2024, the Board of Directors approved a share-based
compensation arrangement for specified directors and officers. The arrangement established fixed annual dollar amounts of compensation,
earned quarterly, with the number of shares for each quarter determined using the average closing price of the Company’s common
stock during the final five trading days of that quarter. The shares were to be issued every six months.
While the number of shares for a quarter remained variable, the award
represented a fixed monetary obligation payable in a variable number of shares. At the end of each quarter, the formula fixed the number
of shares earned for that quarter. Because the obligation was thereafter payable only in a fixed number of the Company’s shares,
the Company recorded the amount within additional paid-in capital issuable until settlement.
During the second quarter of 2026, the Company determined that compensation
earned under the arrangement had not been recorded in the applicable prior periods. The compensation was allocated as follows:
Schedule of Share-Based Compensation
| |
| | |
| Period | |
Compensation | |
| October 17-December 31, 2024 | |
$ | 74,432.45 | |
| Year ended December 31, 2025 | |
| 369,663.78 | |
| Three months ended March 31, 2026 | |
| 95,939.25 | |
| Total | |
$ | 540,035.48 | |
The Company evaluated the errors under applicable U.S. GAAP and SEC
materiality guidance and concluded that the errors were not material to the previously issued financial statements. The Company further
concluded that recording the cumulative correction entirely during the second quarter of 2026 would materially distort current-period
results. Accordingly, the Company revised the affected prior-period comparative information presented in these unaudited condensed consolidated
financial statements.
The compensation for the six months ended June 30, 2025 was allocated
equally between the first and second quarters, resulting in $90,559.48 for each quarter.
The revisions increased additional paid-in capital issuable and accumulated
deficit as of December 31, 2025 by $444,096.23. The revisions increased selling, general and administrative expense and net loss for the
three and six months ended June 30, 2025 by $90,559.48 and $181,118.96, respectively. The revisions increased selling, general and administrative
expense and net loss for the three months ended March 31, 2026 by $95,939.25.
On June 1, 2026, the Company issued an aggregate of 115,908 restricted
shares of common stock to seven current and former directors and officers in settlement of the entire $540,035.48 balance recorded within
additional paid-in capital issuable. The issuance increased common stock and additional paid-in capital, eliminated the APIC-issuable
balance, and had no effect on total stockholders’ equity or cash flows. The Company received no cash proceeds from the issuance.
The shares were issued as restricted securities without registration under the Securities Act of 1933, as amended, in reliance on Section
4(a)(2) thereof.
Based on management’s determination that no compensation arrangement
was in effect for services after March 31, 2026, the Company recognized no additional share-based compensation expense for the three months
ended June 30, 2026.
The following tables summarize the effects of the prior-period revisions
on the Company’s previously reported financial information:
Effects of Revisions as of December 31, 2025
| Schedule of Schedule of Error Correction | |
| | | |
| | | |
| | |
| December 31, 2025 | |
Previously Reported | | |
Adjustment | | |
As Revised | |
| Additional paid-in capital issuable | |
$ | - | | |
$ | 444,096 | | |
$ | 444,096 | |
| Accumulated deficit | |
$ | (2,115,918 | ) | |
$ | (444,096 | ) | |
$ | (2,560,014 | ) |
| Total ESG Inc. stockholders’ equity | |
$ | 8,751,493 | | |
$ | - | | |
$ | 8,751,493 | |
Effects of Revisions for the Three and Six Months Ended June 30, 2025
| | |
Q2 2025 Previously
Reported | | |
Adjustment | | |
Q2 2025
As Revised | | |
Six Months 2025
Previously Reported | | |
Adjustment | | |
Six Months 2025
As Revised | |
| Selling, general and administrative expense | |
$ | 5,515 | | |
$ | 90,559 | | |
$ | 96,074 | | |
$ | 11,996 | | |
$ | 181,119 | | |
$ | 193,115 | |
| Loss from continuing operations | |
| (5,515 | ) | |
| (90,559 | ) | |
| (96,074 | ) | |
| (32,496 | ) | |
| (181,119 | ) | |
| (213,615 | ) |
| Net income | |
| 696,402 | | |
| (90,559 | ) | |
| 605,843 | | |
| 420,249 | | |
| (181,119 | ) | |
| 239,130 | |
| Net income attributable to ESG Inc. | |
| 517,554 | | |
| (90,559 | ) | |
| 426,995 | | |
| 304,890 | | |
| (181,119 | ) | |
| 123,771 | |
| Comprehensive income attributable to ESG Inc. | |
$ | 647,192 | | |
$ | (90,559 | ) | |
$ | 556,633 | | |
$ | 726,414 | | |
$ | (181,119 | ) | |
$ | 545,295 | |
Effects of Revisions for the Three Months Ended March 31, 2026
| Three Months Ended March 31, 2026 | |
Previously Reported | | |
Adjustment | |
|
As Revised | |
| Selling, general and administrative expense | |
$ | 29,314 | | |
$ | 95,939 | |
|
$ | 125,253 | |
| Loss from continuing operations | |
| (51,915 | ) | |
| (95,939 | ) |
|
| (147,854 | ) |
| Net loss | |
| (884,051 | ) | |
| (95,939 | ) |
|
| (979,990 | ) |
| Net loss attributable to ESG Inc. | |
| (682,215 | ) | |
| (95,939 | ) |
|
| (778,154 | ) |
| Comprehensive loss attributable to ESG Inc. | |
$ | (552,129 | ) | |
$ | (95,939 | ) |
|
$ | (648,068 | ) |
Note 8 - Commitments and Contingencies
Except for the going-concern uncertainty described in Note 2, the split-off
described in Note 4, the former PRC supplier matters described in Part II, Item 1, and the convertible-note obligations and default described
in Note 6.
Moku License Agreement. On February 8, 2026, the Company entered
into an Intellectual Property & Brand License Agreement with Moku Foods, Inc. Pursuant to the agreement, the Company agreed to cause
shares of its common stock having a stated value of $100,000 to be issued to an escrow agent as contingent consideration, subject to the
release conditions set forth in the agreement. No shares had been issued by the Company’s transfer agent under this arrangement
as of June 30, 2026, and no such shares are included in the Company’s issued and outstanding common stock as of June 30, 2026. Moku
has no beneficial ownership, voting, dividend or transfer rights with respect to the contingent shares unless and until shares are issued
and released in accordance with the agreement.
The Company was not subject to other material commitments or contingencies
as of June 30, 2026.
Note 9 - Subsequent Events
Management evaluated subsequent events through August 14, 2026, the
date on which these unaudited condensed consolidated financial statements were available to be issued.
On August 5, 2026, the Labrys Fund II, L.P. convertible promissory
note reached its stated maturity. The outstanding principal, accrued interest and other amounts due under the note remained unpaid, and
the Event of Default described in Note 6 remained uncured.
On August 7, 2026, Labrys agreed that,
in consideration of a $1,000 payment by the Company, it would forbear from exercising its conversion rights under the note for 90 days
commencing upon receipt of the payment. Labrys received the $1,000 payment on August 13, 2026, and the conversion-forbearance period
commenced on that date and expires on November 11, 2026. The $1,000 payment constituted consideration for the forbearance and did not
reduce the outstanding principal balance.
The forbearance is limited to the exercise
of conversion rights and does not cure the existing Event of Default, extend the note's stated maturity date, suspend the accrual of
contractual default interest or otherwise modify the amounts payable under the note.
No other subsequent event requiring recognition or disclosure was identified.
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
You should read the following discussion and analysis together with
the unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited
consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2025.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding, among
other matters, our plans, objectives, expectations, financing and liquidity needs, operating strategy, the anticipated effects of the
completed split-off of our China operations, the development and commercialization of our North American food products, and other future
events and circumstances.
Forward-looking statements are based on management’s
current expectations, estimates, assumptions and projections and are subject to risks, uncertainties and other factors that could cause
actual results to differ materially from those expressed or implied by such statements. Readers should not place undue reliance on these
forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any
forward-looking statement, whether as a result of new information, future events or otherwise.
Overview
On May 26, 2026, the Company completed the split-off of its China operations
pursuant to the Split-Off and Share Exchange Agreement described in Note 4 to the unaudited condensed consolidated financial statements.
In connection with the transaction, the Company transferred its ownership of ESG China Limited and its subsidiaries, and 10,432,800 shares
of the Company’s common stock were surrendered and canceled. The former China operations ceased to be consolidated effective May
26, 2026 and are presented as discontinued operations for all periods presented.
Following the split-off, the Company’s continuing operations
consist of its early-stage North American food and snack business conducted through ESG Provisions, Inc. The Company is developing and
commercializing mushroom-based snacks and alternative-protein products through product development, sourcing, packaging, co-manufacturing,
e-commerce and other commercialization activities.
The continuing business generated limited revenue during the six months
ended June 30, 2026 and remains dependent on additional financing, successful product commercialization, third-party suppliers and manufacturers,
production readiness, supply-chain execution and customer acceptance.
Results of Operations
Revenue, Cost of Goods Sold and Gross Profit
Revenue from continuing operations was $918 for both the three and
six months ended June 30, 2026, compared with no revenue during the corresponding 2025 periods.
Cost of goods sold was $555 for both the three and six months ended
June 30, 2026, resulting in gross profit of $363 and a gross margin of approximately 39.5%. The continuing business remains in an early
commercialization stage, and the results are not necessarily indicative of future periods.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $1,610 for the three
months ended June 30, 2026, compared with $96,074 for the corresponding 2025 period, as revised. The decrease of $94,464, or approximately
98.3%, principally reflected $90,559 of share-based compensation included in the revised 2025 period and the limited level of continuing
operations during the 2026 quarter.
For the six months ended June 30, 2026, selling, general and administrative
expenses were $126,863, compared with $193,115 for the corresponding 2025 period, as revised. The 2026 amount included $95,939 of share-based
compensation attributable to the three months ended March 31, 2026. The 2025 amount included $181,119 of revised share-based compensation.
On June 1, 2026, the Company issued 115,908 restricted shares in settlement
of $540,035.48 of compensation earned through March 31, 2026. The issuance did not result in additional second-quarter expense and had
no effect on cash flows. See Note 7.
Professional Fees
Professional fees were $0 and $15,820 for the three and six months
ended June 30, 2026, respectively, compared with $0 and $20,500 for the corresponding 2025 periods. The six-month decrease of $4,680 primarily
reflected the timing of legal, accounting, audit and other professional services.
Interest Expense
Interest
expense was $26,036 and $32,817 for the three and six months ended June 30, 2026, respectively, compared with no interest expense during
the corresponding 2025 periods. The 2026 expense resulted from the Company’s convertible notes, including stated interest and amortization
of debt discounts and approximately
$13,110 of additional default interest recognized during the second quarter of 2026 under the Labrys Fund II, L.P. convertible promissory
note. See Note 6 to the unaudited condensed consolidated financial statements.
Loss from Continuing Operations and Net Loss
Loss from continuing operations was $27,283
for the three months ended June 30, 2026, compared with $96,074 for the corresponding 2025 period, as revised. For the six months ended
June 30, 2026, loss from continuing operations was $175,137, compared with $213,615 for the corresponding 2025 period, as revised. The
2026 losses included interest expense associated with the Company’s convertible notes, including the additional default interest
recognized under the Labrys note described above.
Loss from discontinued operations was
$46,206 and $878,342 for the three and six months ended June 30, 2026, respectively. Income from discontinued operations was $701,917
and $452,745 for the corresponding 2025 periods.
Consolidated net loss was $73,489 and
$1,053,479 for the three and six months ended June 30, 2026, respectively, compared with consolidated net income of $605,843 and
$239,130 for the corresponding 2025 periods, as revised.
Liquidity and Capital Resources
As of June 30, 2026, the Company had cash
of $161,100, current assets of $190,745 and current liabilities of $564,916, resulting in a working-capital deficit of $374,171. Current
liabilities included accounts payable of $64,324, accrued interest payable of $19,522 and convertible notes payable, net, of $481,070.
The aggregate outstanding principal of the convertible notes was $495,000.
The Company’s continuing operations
generated only $918 of revenue during the six months ended June 30, 2026 and have not generated sufficient cash flow to fund operating
expenses, public-company costs, working-capital requirements and debt obligations. Existing cash and expected operating cash flows are
not expected to be sufficient to meet the Company’s obligations for the twelve months following issuance of the financial statements.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern, and management’s plans
have not alleviated that doubt.
Management’s plans include seeking
additional debt or equity financing, negotiating extensions, conversions or modifications of outstanding debt, controlling operating
expenses, commercializing the Company’s North American products and evaluating strategic transactions. Financing may not be available
when required or on acceptable terms. Failure to obtain financing or generate sufficient operating cash flow could require the Company
to delay product launches, reduce operations, default on obligations or pursue a restructuring or other strategic transaction.
Cash Flows
Operating Activities
Net cash used in operating activities was $57,847 for the six months
ended June 30, 2026, compared with $1,531,277 for the corresponding 2025 period.
Continuing operations used $84,905 of cash during the six months ended
June 30, 2026, compared with $40,992 during the corresponding 2025 period. The 2026 reconciliation included a noncash share-based compensation
adjustment of $95,939.
Discontinued operations provided $27,058 of cash during the six months
ended June 30, 2026 and used $1,490,285 during the corresponding 2025 period.
Investing Activities
Continuing operations had no investing cash flows during either period.
Discontinued operations had no investing cash flows during the six months ended June 30, 2026 and used $208,253 during the corresponding
2025 period.
Financing Activities
Continuing operations received $200,000 of net financing cash flows
during the six months ended June 30, 2026 from the Monroe and Crom convertible-note financings. Continuing operations had no financing
cash flows during the corresponding 2025 period.
Discontinued operations had no financing cash flows during the six
months ended June 30, 2026 and provided $1,341,253 during the corresponding 2025 period.
The Company transferred $38,493 of cash and restricted cash in connection
with the China split-off and recorded a $22,431 adverse effect of exchange-rate changes on cash and restricted cash. Cash and restricted
cash increased by $81,229, from $79,871 at December 31, 2025 to $161,100 at June 30, 2026.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
As a smaller reporting company, the Company is not required to provide
the information required by this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Management, with the participation of the Company’s principal
executive officer and principal financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures,
as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of June 30, 2026.
Based on that evaluation, the Company’s principal executive officer
and principal financial officer concluded that the Company’s disclosure controls and procedures were not effective as of June 30,
2026 due to a material weakness in the Company’s internal control over financial reporting.
The material weakness relates to insufficient formal written accounting
and financial-reporting policies, procedures and review controls to ensure that complex and nonroutine transactions are timely identified,
analyzed, documented, approved, recorded and disclosed in accordance with U.S. generally accepted accounting principles and applicable
SEC reporting requirements. This weakness could affect the Company’s accounting for and disclosure of matters including equity compensation,
convertible debt, related-party transactions, deconsolidation and discontinued operations.
During the preparation of the unaudited condensed consolidated financial
statements for the quarter ended June 30, 2026, the Company determined that its controls did not result in the timely identification,
accounting, documentation and review of share-based compensation earned by directors and officers through March 31, 2026. The Company
revised the affected prior-period comparative information and recorded the June 1, 2026 settlement through the issuance of shares. The
material weakness had not been remediated as of June 30, 2026.
Changes in Internal Control over Financial Reporting
The completion of the split-off of ESG China Limited on May 26, 2026
materially changed the scope of the Company’s internal control over financial reporting because the former China operations were
removed from the Company’s consolidation and financial-reporting processes. In connection with the transaction, the Company implemented
or modified processes addressing deconsolidation, discontinued-operations reporting, derecognition of assets, liabilities and noncontrolling
interests, and cancellation of the related common shares.
Except for the changes described above, there were no changes in the
Company’s internal control over financial reporting during the quarter ended June 30, 2026 that materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
There were no material developments during the quarter ended June 30,
2026 in the legal proceedings previously disclosed in Part II, Item 1 of the Company’s Quarterly Report on Form 10-Q for the quarter
ended March 31, 2026. The former PRC operating entities involved in those supplier and contract payment disputes ceased to be subsidiaries
of the Company upon completion of the split-off on May 26, 2026. Based on management’s review, no material claim arising from those
matters has been asserted against ESG Inc. or any continuing subsidiary.
Item 1A. Risk Factors
As a smaller reporting company, the Company is not required to provide
the information required by this Item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Unregistered Sales of Equity Securities
On April 13, 2026, Labrys Fund II, L.P. converted $8,330 of accrued
interest and a $1,750 conversion fee under the Company’s convertible promissory note into 6,000 shares of common stock at a conversion
price of $1.68 per share. No principal was converted, and the Company received no cash proceeds from the conversion. The shares were issued
without registration under the Securities Act of 1933, as amended, in reliance on Section 3(a)(9) thereof and, alternatively, Section
4(a)(2) thereof.
On June 1, 2026, the Company issued an aggregate of 115,908 restricted
shares of common stock to seven current and former directors and officers as equity compensation for services rendered from October 17,
2024 through March 31, 2026. The shares represented aggregate compensation of $540,035.48 calculated under the Company’s Board-approved
equity-compensation arrangements. The Company received no cash proceeds from the issuance. The shares were issued without registration
under the Securities Act in reliance on Section 4(a)(2) thereof.
Issuer Purchases of Equity Securities
| Period | |
Total Number of Shares Purchased | | |
Average Price Paid per Share | | |
Total Number Purchased as Part of Publicly Announced Plans or Programs | | |
Maximum Number or Approximate Dollar Value That May Yet Be Purchased | |
| April 1–April 30, 2026 | |
|
— | | |
|
— | | |
|
— | | |
|
— | |
| May 1–May 31, 2026 | |
| 10,432,800 | | |
| N/A | (1) | |
| — | | |
| — | |
| June 1–June 30, 2026 | |
| — | | |
| — | | |
| — | | |
| — | |
| Total | |
| 10,432,800 | | |
| N/A | (1) | |
| — | | |
| — | |
(1) On May 26, 2026, pursuant to the Split-Off and Share Exchange Agreement,
the Company transferred all of the outstanding equity interests of ESG China Limited in exchange for the surrender, redemption, retirement
and cancellation of 10,432,800 shares of the Company’s common stock. The transaction was a noncash exchange, and no cash purchase
price was paid. The shares were not acquired pursuant to a publicly announced share-repurchase plan or program.
Item 3. Defaults Upon Senior Securities
As previously reported in the Company’s Current Report on Form
8-K filed on February 9, 2026, the Company did not make the $151,250 amortization payment due on February 5, 2026 under its convertible
promissory note issued to Labrys Fund II, L.P. The failure to make that payment constituted an Event of Default and triggered the holder’s
conversion and acceleration rights.
As of the filing date, the Company had made no scheduled cash payments
under the note, no principal had been converted, and the outstanding principal remained $275,000. On August 5, 2026, the note reached
its stated maturity, at which time all remaining outstanding principal, accrued interest and other amounts became due and payable. As
of August 14, 2026, the total principal and accrued-interest arrearage under the note was approximately $301,981, consisting of $275,000
of outstanding principal and approximately $26,981 of accrued interest. The Event of Default remained uncured.
On August 7, 2026, Labrys agreed that,
in consideration of a $1,000 payment by the Company, it would forbear from exercising its conversion rights under the note for a period
of 90 days commencing upon receipt of the payment. Labrys received the $1,000 payment on August 13, 2026, and the 90-day conversion-forbearance
period commenced on that date and expires on November 11, 2026. The $1,000 payment constituted consideration for the forbearance and
did not constitute repayment of principal under the note.
The forbearance is limited to the holder’s
exercise of conversion rights during the applicable 90-day period. It does not cure or waive the existing Event of Default, extend the
note’s stated maturity date, reduce the outstanding principal balance, suspend the accrual of contractual default interest or otherwise
modify the amounts payable under the note. Except for the temporary conversion forbearance, the holder retains its rights and remedies
under the note.
Under the terms of the note, following
an Event of Default the holder may claim a contractual default amount equal to 150% of the outstanding principal and accrued interest,
including applicable default interest, together with collection costs. Accordingly, the holder’s total contractual claim may exceed
the scheduled cash-payment arrearage stated above.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the fiscal quarter ended June 30, 2026, no director or officer
of the Company, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, adopted or terminated a Rule 10b5-1 trading arrangement
or a non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
The following exhibits are filed or furnished as part of this Quarterly
Report:
| Exhibit |
|
Description |
| 2.1 |
|
Split-Off and Share Exchange Agreement, dated April 10, 2026, by and among ESG Inc., DCG China Limited, Christopher Alonzo, Ever Vast Development Ltd. and Weiwei Gao, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 13, 2026. |
| 3.1 |
|
Articles of Incorporation, incorporated by reference to Exhibit 3.1(a) to the Company’s Registration Statement on Form S-1 filed September 24, 2021. |
| 3.2 |
|
Articles of Merger between Plasma Innovative Inc. and ESG Inc., effective November 27, 2023, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed December 1, 2023. |
| 3.3 |
|
Amended and Restated Bylaws of ESG Inc., effective February 24, 2025, incorporated by reference to Exhibit 3.5 to the Company’s Quarterly Report on Form 10-Q filed November 14, 2025. |
| 10.1*† |
|
Secretary’s Certified Extract from Board Minutes and Written Description of Subsequent Modification to Share Compensation Arrangement, dated July 31, 2026. |
| 31.1* |
|
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. |
| 31.2* |
|
Certification of the Principal Financial and Accounting Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. |
| 32.1** |
|
Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350. |
| 32.2** |
|
Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350. |
| 101* |
|
Inline XBRL documents. |
| 104* |
|
Cover Page Interactive Data File, embedded within the Inline XBRL document. |
| † | Management contract or compensatory plan or arrangement. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ESG INC. |
|
| |
|
|
| Date: |
August 14, 2026 |
|
| |
|
|
| By: |
/s/ Zhi Yang |
|
| Name: |
Zhi Yang |
|
| Title: |
Chief Executive Officer |
|
| |
(Principal Executive Officer) |
|
| |
|
|
| By: |
/s/ Edward F. Gobora |
|
| Name: |
Edward F. Gobora |
|
| Title: |
Chief Financial Officer |
|
| |
(Principal Financial and Accounting Officer) |
|